Login to Your Account

Pharma: Other News To Note

Tuesday, December 3, 2013
• Gland Pharma Ltd., of Mumbai, India, said KKR, a global investment firm, will acquire a minority stake in the generics company for approximately $200 million, including KKR’s acquisition of the entire stake held by Evolvence India Life Sciences Fund, an existing private equity investor in Gland Pharma.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription